Learn more

ZELTIA S A

Overview
  • Total Patents
    21
About

ZELTIA S A has a total of 21 patent applications. Its first patent ever was published in 1941. It filed its patents most often in Spain, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are FUNDACIÓN CT NAC DE INVESTIGACIONES ONCOLÓGICAS CARLOS III, UROGENE and EISAI LONDON RES LAB LTD.

Patent filings per year

Chart showing ZELTIA S As patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Santamaria Nunez Gema 7
#2 Martinez Diez Marta 6
#3 Martinez Gil Ana 5
#4 Alonso Cascon Mercedes 5
#5 Lopez Ogalla Javier 4
#6 Cascon Mercedes Alonso 3
#7 Nunez Gema Santamaria 3
#8 Diez Marta Martinez 3
#9 Ogalla Javier Lopez 3
#10 Gil Ana Martinez 3

Latest patents

Publication Filing date Title
EP2213286A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes and cardiovascular diseases
EP2020232A1 N-(1-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
EP2020447A1 Method for identifying compounds modulating adiponectin gene expression
ES168516A1 Procedure for the obtection of a given medium of parasiticide properties
ES168517A1 Procedure for obtaining an insecticide product
ES168518A1 Procedure for obtaining an insecticide medium
ES153781A1 A condensation procedure of quinolein, isoquinolein and pyridine, as well as its halogenated derivatives, nitrated and aminated with para-acetylamine-benzene-sulfonamide
ES153776A1 Ergometrine manufacturing procedure
ES153775A1 1-efedrine manufacturing procedure
ES153778A1 Procedure for the industrial production of azoic combinations that also possess the sulfonamide function in position for the azoico group
ES153777A1 Industrial procedure for sulfonamide function rent
ES153779A1 Procedure for the industrial obtaining of bodies formed by replacing the hydrogen of the aminic function by aromatic radicals in bodies that possess, in addition, the sulfonamide function